You are here:

Home
NICE Guidance
Published Guidance

Dupilumab for treating moderate to severe prurigo nodularis

Technology appraisal guidance
Reference number: TA955
Published: 13 March 2024

Guidance
Tools and resources
Information for the public
Evidence
History

Tools and resources

Tools to help you put the guidance into practice.

Guidance into practice

About the Into practice guide
Practical steps to improving the quality of care and services using NICE guidance